Company Analysis

Daxor Corporation (DXR)

Nasdaq: DXR · filing with the SEC since 1995
Grade4.1
◀ Past 3.6● Present 4.0▶ Future 4.7
6 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

8 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Daxor Corporation’s names, not what it holds today.

Patents granted
8
7 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 1 in 2023
Applications published
13
1 of them in 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
'91'96'08'13'15'18'20'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name1 counted
DAXOR CORP. its own name
US, as the owner printed on each patent
8 granted
13 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Apr 29, 2025D1,073,064SyringeDAXOR CORP.
Jan 2, 202411,862,311Blood volume analyzer with guidanceMedical technologyDAXOR CORP.
Oct 31, 202311,801,002Remote blood volume monitorMedical technologyDAXOR CORP.
Dec 21, 202111,204,356Blood volume analysis with volume-aware blood component measures and treatmentMedical technologyDAXOR CORP.
Apr 7, 20159,002,657Automated blood analyzerMedical technologyDAXOR CORP.
Apr 7, 20159,002,656Automated total body albumin analyzerMedical technologyDAXOR CORP.
Jun 25, 19965,529,189Syringe assembly for quantitative measurement of radioactive injectate and kit having sameMedical technologyDAXOR CORP.
Jun 18, 19915,024,231Automated multi-point blood volume analyzerMedical technologyDAXOR CORP.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 29, 20252025/0172575QUANTITATIVE BLOOD COLLECTION VIAL AND SYSTEM AND METHOD FOR DETERMINING HEMATOCRITAnalysis of biological materialsDAXOR CORP.
Jan 18, 20242024/0016421REMOTE BLOOD VOLUME MONITORMedical technologyDAXOR CORP.
Apr 27, 20232023/0131712BLOOD VOLUME MEASUREMENT WITH FLUORESCENT DYEAnalysis of biological materialsDAXOR CORP.
Feb 16, 20232023/0049988FLUORESCENT DYE IN TERNARY COMPLEXPharmaceuticalsDAXOR CORP.
Sep 24, 20202020/0297259REMOTE BLOOD VOLUME MONITORMedical technologyDAXOR CORP. · patent 11,801,002 granted from it
Apr 30, 20202020/0132677WHOLE BLOOD VOLUME ANALYZERMedical technologyDAXOR CORP.
Apr 30, 20202020/0132676BLOOD VOLUME ANALYZER WITH GUIDANCEMedical technologyDAXOR CORP. · patent 11,862,311 granted from it
Apr 30, 20202020/0132668FLOW-THROUGH QUANTITATIVE BLOOD COLLECTION VIALSemiconductorsDAXOR CORP.
Aug 2, 20182018/0217168BLOOD VOLUME ANALYZER WITH VOLUME-AWARE BLOOD COMPONENT MEASURESMedical technologyDAXOR CORP. · patent 11,204,356 granted from it
Apr 18, 20132013/0096846AUTOMATED BLOOD ANALYZERMedical technologyDAXOR CORP. · patent 9,002,657 granted from it
What it applied for, 2024 to 2025: Medical technology 1 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton DXR · research, not advice